Search

everythinglearnresearchcommunity

for

Search:↓

Flutamide, dutasteride, and finasteride dissolve differently in supercritical carbon dioxide, with dutasteride dissolving the least.

Pharmacists play a crucial role in patient education and personalized care.

Valproic acid may cause hair loss by reducing biotinidase enzyme activity in rats.

A woman's severe skin reaction was caused by an allergy to a skin treatment.

The retired colonel's ankle swelling was caused by a reaction to the antibiotic levofloxacin.

Ruxolitinib can cause a delayed skin reaction on the nose.

Common dermatology drugs were considered but are controversial for COVID-19 treatment.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Ritlecitinib was generally well tolerated in children with alopecia areata.

5-alpha-reductase inhibitors can effectively treat benign prostatic hyperplasia.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Setipiprant did not significantly improve hair growth in men with hair loss.

Intralesional cidofovir might be a good alternative treatment.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Dutasteride use can lead to a stable decline in sexual function that is not affected by age or prostate size.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

The two finasteride tablets are bioequivalent.

Antituberculosis drugs can cause severe skin reactions, requiring careful diagnosis and treatment.

Balancing testosterone may reduce COVID-19 severity.

Phenytoin and spironolactone help prevent hair loss from chemotherapy by reducing stress and inflammation.

Low-dose finasteride may cause lasting sexual dysfunction and suicidal thoughts in young men.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Urologists should screen for mental health issues before and during finasteride treatment.

A new compound may treat benign prostatic hyperplasia better than finasteride.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.